That is the logistics I'm talking about. Testing was incredibly slow to scale up last spring, and scaling up tests for antibodies as well seems like unnecessary

That is the logistics I'm talking about. Testing was incredibly slow to scale up last spring, and scaling up tests for antibodies as well seems like unnecessary complication. We need fewer moving parts, not more.